Clinical Trials in Denver

Showing 7221-7240 of 13,773 trials

Study of Efficacy and Safety of LOU064 in Inadequately Controlled Asthma Patients

NCT03944707

This was a proof-of-concept study to evaluate the efficacy of LOU064 in patients with inadequately controlled asthma. All subjects were randomized with 3:2 ratio to receive LOU064 100 mg once daily or LOU064 matching placebo for 12 weeks with standard background therapy of budesonide 80 µg/formoterol 4.5 µg two inhalations twice a day (b.i.d).

Asthma

Novartis Pharmaceuticals76 participantsStarted Jul 2019

Denver, Colorado, United States • North Dartmouth, Massachusetts, United States • St Louis, Missouri, United States +16 more locations

UNKNOWNNA< 1 mile

Effectiveness of Vaporous Hyperoxia Therapy (VHT) in the Treatment of Chronic Diabetic Foot Ulcers

NCT04210609

The purpose of this study is to evaluate the effectiveness of Vaporous Hyperoxia Therapy (VHT) for the treatment of Diabetic Foot Ulcers.

Diabetic Foot Ulcer

Vaporox30 participantsStarted Oct 2021

Castle Rock, Colorado, United States • Denver, Colorado, United States • Denver, Colorado, United States

Study of Efficacy and Safety of LOU064 in Inadequately Controlled Asthma Patients

Effectiveness of Vaporous Hyperoxia Therapy (VHT) in the Treatment of Chronic Diabetic Foot Ulcers

Find Trials by Condition in Denver

Study to Assess the Efficacy and Safety of CJM112 in Patients With Inadequately Controlled Severe Asthma

Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis

A 12 Week Randomized Open Label Parallel Group Multicenter Study to Evaluate Bioequivalence of 20 mg Subcutaneous Ofatumumab Injected by Pre-filled Syringe or Autoinjector in Adult RMS Patients

Use of 3,4-Diaminopyridine in the Treatment of Lambert-Eaton Syndrome

Fenestrated AAA Endovascular Graft Post-Approval Study

A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod

Study to Evaluate the Safety and Efficacy of Secukinumab 300 mg and 150 mg in Adult Patients With Active Psoriatic Arthritis (PsA) After 16 Weeks of Treatment Compared to Placebo

Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder

A Study of ALKS 3831 in Adults With Schizophrenia

A Phase 2 Study to Evaluate Immune Responses of FluMist®

Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia

The (PIVOTAL) Study

A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder

Five Year Study to Track Use of DecisionDX-Melanoma Test in Patients With Cutaneous Melanoma and Associated Patient Outcomes

Study of UCART19 in Pediatric Patients With Relapsed/Refractory B Acute Lymphoblastic Leukemia

Effectiveness of Virtual Reality Gaming Therapy Versus CI Therapy for Upper Extremity Rehabilitation

Study of Efficacy of Fevipiprant in Patients With Nasal Polyposis and Asthma

Phase 2 Study of Zevalin Versus Zevalin and Motexafin Gadolinium in Patients With Rituximab-Refractory Low-grade or Follicular B-cell Non-Hodgkin's Lymphoma